MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by pathological features such as tau protein aggregation and hyperphosphorylation, chronic neuroinflammation, and cholinergic dysfunction mediated by acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE).